CRIS

Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM Total revenue 3.35 M2.38 M2.75 M3.18 M1.14 M 9.44 M Gross profit 3.35 M2.38 M2.75 M3.18 M1.14 M 9.44 M Operating expenses 12.34 M12.54 M11 M10.1 M8.71 M 42.34 M Selling/general/admin expenses 3.35 M3.98 M3.53 M3.65 M2.88 M 14.05 M Research & development 8.97 M8.54 M7.46 M6.43 M5.83 M 28.25 M Operating income -8.99 M-10.16 M-8.25 M-6.92 M19.62 M -5.71 M Non-Operating Income, Total -624 K-459 K-342 K-805 K-263 K -1.87 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses -624 K-459 K-342 K-805 K-263 K -1.87 M Unusual income/expense ————— — Pretax income -9.62 M-10.62 M-8.59 M-7.73 M19.36 M -7.58 M Equity in earnings ————— — Taxes ————2.53 M — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -9.62 M-10.62 M-8.59 M-7.73 M19.36 M -7.58 M Discontinued operations ————— — Net income -9.62 M-10.62 M-8.59 M-7.73 M19.36 M -7.58 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -9.62 M-10.62 M-8.59 M-7.73 M19.36 M -7.58 M Basic earnings per share (Basic EPS) -1.1-1.25-0.68-0.491.84 -0.58 Diluted earnings per share (Diluted EPS) -1.1-1.25-0.68-0.491.84 -0.58 Average basic shares outstanding 6.31 M8.49 M12.63 M15.68 M13.16 M 49.97 M Diluted shares outstanding 6.31 M8.49 M12.63 M15.68 M13.16 M 49.97 M EBITDA -8.57 M-10.16 M-8.25 M-6.92 M-7.57 M -32.9 M EBIT -8.99 M-10.16 M-8.25 M-6.92 M-7.57 M -32.9 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 428 K0000 0